Natixis’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $46M | Sell |
|
|||||
|
2025
Q1 | $70.1M | Sell |
|
|||||
|
2024
Q4 | $140M | Buy |
|
|||||
|
2024
Q3 | $52.5M | Buy |
|
|||||
|
2024
Q2 | $39.1M | Sell |
|
|||||
|
2024
Q1 | $79.8M | Buy |
|
|||||
|
2023
Q4 | $52.3M | Buy |
|
|||||
|
2023
Q3 | $34.6M | Sell |
|
|||||
|
2023
Q2 | $44.5M | Sell |
|
|||||
|
2023
Q1 | $54.9M | Sell |
|
|||||
|
2022
Q4 | $155M | Buy |
|
|||||
|
2022
Q3 | $121M | Buy |
|
|||||
|
2022
Q2 | $126M | Buy |
|
|||||
|
2022
Q1 | $75.2M | Sell |
|
|||||
|
2021
Q4 | $87.3M | Sell |
|
|||||
|
2021
Q3 | $127M | Sell |
|
|||||
|
2021
Q2 | $227M | Buy |
|
|||||
|
2021
Q1 | $50.2M | Sell |
|
|||||
|
2020
Q4 | $170M | Buy |
|
|||||
|
2020
Q3 | $140M | Buy |
|
|||||
|
2020
Q2 | $19.9M | Sell |
|
|||||
|
2020
Q1 | $109M | Buy |
|
|||||
|
2019
Q4 | $61.1M | Buy |
|
|||||
|
2019
Q3 | $53.1M | Sell |
|
|||||
|
2019
Q2 | $258M | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $166M | Sell |
|
|||||
|
2018
Q3 | $184M | Buy |
|
|||||
|
2018
Q2 | $103M | Buy |
|
|||||
|
2018
Q1 | $41M | Sell |
|
|||||
|
2017
Q4 | $148M | Buy |
|
|||||
|
2017
Q3 | $125M | Buy |
|
|||||
|
2017
Q2 | $91.6M | Buy |
|
|||||
|
2017
Q1 | $55.4M | Buy |
|
|||||
|
2016
Q4 | $19.1M | Sell |
|
|||||
|
2016
Q3 | $30.5M | Buy |
|
|||||
|
2016
Q2 | $18M | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $123M | Buy |
|
|||||
|
2015
Q3 | $113M | Sell |
|
|||||
|
2015
Q2 | $122M | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $70M | Sell |
|
|||||
|
2014
Q3 | $225M | Buy |
|
|||||
|
2014
Q2 | $164M | Buy |
|
|||||
|
2014
Q1 | $165M | Sell |
|
|||||
|
2013
Q4 | $220M | Buy |
|
|||||
|
2013
Q3 | $147M | Buy |
|
|||||
|
2013
Q2 | $22.9M | Buy |
|